Taub Rebecca sold MDGL
August 12, 2025 · Form 4 insider transaction
Taub Rebecca sold 1,175 shares of Madrigal Pharmaceuticals, Inc. at $352.45 per share, a transaction worth $414.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,175
Price
$352.45
Total value
$414.1K
InsiderTaub Rebecca
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 12, 2025
Filing dateAugust 13, 2025
Shares owned after496,682
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.17 to $353.01, inclusive.